Medicare Part D, which previously banned direct Drug price negotiations, will now be able to negotiate individual drug prices for all beneficiaries. This is a historic step that will result in lower drug prices for some individuals, especially for lower-priced chronic disease medications. Additionally, the new negotiated prices will go into effect in 2026, while the new $2,000 out-of-pocket cap will be implemented in 2025. The negotiation is being used to fund the expansion of benefits, ensuring that premiums do not have to increase.

The post Medicare Drug price negotiations could save government billions appeared first on Balanced News Summary.